Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (201-210 of 760) with videos related to

Pageof 76
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 23, 2004
Late stent thrombosis (> 1 year) following clopidogrel withdrawal after brachytherapy treatment: need to assess aspirin resistance?Pilar Jiménez-Quevedo, Dominick J Angiolillo, Esther Bernardo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 5, 2025
Oral anticoagulation alone in atrial fibrillation and stable coronary artery disease: evidence silences doubtFelice Gragnano, Vincenzo De Sio, Dominick J Angiolillo, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCIAntonio Greco, Maria Sara Mauro, Davide Capodanno, et al.
Diabetes & Vascular Disease Research|October 6, 2010
Platelet abnormalities in diabetes mellitusJosé Luis Ferreiro, Joan Antoni Gómez-Hospital, Dominick J Angiolillo
Expert Opinion on Pharmacotherapy|October 22, 2008
Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical developmentDominick J Angiolillo, Siva Suryadevara, Piera Capranzano, et al.
Expert Opinion on Drug Safety|November 6, 2025
Long-term safety of oral antiplatelet strategies for patients with acute coronary syndrome undergoing percutaneous coronary interventionClaudio Laudani, Luis Ortega-Paz, Davide Capodanno, et al.
Journal of Cardiovascular Translational Research|February 14, 2013
Platelet function profiles in patients with diabetes mellitusFabiana Rollini, Francesco Franchi, Ana Muñiz-Lozano, et al.
Journal of the American Heart Association|November 24, 2020
Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic ManagementLuis Ortega-Paz, Davide Capodanno, Gilles Montalescot, et al.
Revista Espanola De Cardiologia|May 21, 2004
[Inflammation in acute coronary syndromes: mechanisms and clinical implications]Dominick J Angiolillo, Luigi M Biasucci, Giovanna Liuzzo, et al.
Expert Opinion on Investigational Drugs|November 1, 2018
CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarctionDavide Capodanno, Roxana Mehran, C Michael Gibson, et al.
Pageof 76

Showing results (201-210 of 760) with videos related to

Sort By:
Pageof 76
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 23, 2004
Late stent thrombosis (> 1 year) following clopidogrel withdrawal after brachytherapy treatment: need to assess aspirin resistance?Pilar Jiménez-Quevedo, Dominick J Angiolillo, Esther Bernardo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 5, 2025
Oral anticoagulation alone in atrial fibrillation and stable coronary artery disease: evidence silences doubtFelice Gragnano, Vincenzo De Sio, Dominick J Angiolillo, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCIAntonio Greco, Maria Sara Mauro, Davide Capodanno, et al.
Diabetes & Vascular Disease Research|October 6, 2010
Platelet abnormalities in diabetes mellitusJosé Luis Ferreiro, Joan Antoni Gómez-Hospital, Dominick J Angiolillo
Expert Opinion on Pharmacotherapy|October 22, 2008
Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical developmentDominick J Angiolillo, Siva Suryadevara, Piera Capranzano, et al.
Expert Opinion on Drug Safety|November 6, 2025
Long-term safety of oral antiplatelet strategies for patients with acute coronary syndrome undergoing percutaneous coronary interventionClaudio Laudani, Luis Ortega-Paz, Davide Capodanno, et al.
Journal of Cardiovascular Translational Research|February 14, 2013
Platelet function profiles in patients with diabetes mellitusFabiana Rollini, Francesco Franchi, Ana Muñiz-Lozano, et al.
Journal of the American Heart Association|November 24, 2020
Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic ManagementLuis Ortega-Paz, Davide Capodanno, Gilles Montalescot, et al.
Revista Espanola De Cardiologia|May 21, 2004
[Inflammation in acute coronary syndromes: mechanisms and clinical implications]Dominick J Angiolillo, Luigi M Biasucci, Giovanna Liuzzo, et al.
Expert Opinion on Investigational Drugs|November 1, 2018
CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarctionDavide Capodanno, Roxana Mehran, C Michael Gibson, et al.
Pageof 76